Marpai, Inc. (MRAI)
Marpai, Inc. operates in the Medical - Healthcare Plans industry of the Healthcare sector, headquartered in Tampa, FL, US. The stock last traded at $3.16, up 3.61% on the session, giving a market capitalisation of $79.9M. On trailing twelve-month figures it carries a trailing P/E of -4.10, a net margin of -101.5%. Its beta of 4.71 implies it has historically moved more than the broad market.
Marpai, Inc. operates as a technology-driven healthcare payer, concentrating its efforts on the self-insured employer market within the United States and Israel. The firm provides a comprehensive suite of supplementary services, which includes managing patient care and individual cases, actuarial evaluations, administering health savings accounts, and implementing cost-saving measures. Additionally, Marpai innovates in artificial intelligence and healthcare technology. These advanced platforms process data to anticipate and preempt issues such as diagnostic inaccuracies, preventable hospitalizations, and administrative inefficiencies. Incorporated in 2021, the company's main office is situated in New York, New York.
Marpai, Inc. is most often compared with the following Healthcare names: